Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$417,684,905
-$299,889,856 QoQ
Shares Held
1,659,851
-49.7% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#93
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 12%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $5,952,714,959 across 15 Drug Manufacturers - General names. ABBV ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,354,837 | $2,824,462,378 | |
| 2 | JNJ |
Johnson & Johnson
|
2,945,732 | $748,127,556 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,865,967 | $625,276,759 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,959,269 | $500,214,045 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
1,659,851 | $417,684,905 | |
| 6 | AZN |
Astrazeneca PLC
|
1,320,358 | $250,366,283 | |
| 7 | NVS |
Novartis AG
|
707,061 | $110,810,599 | |
| 8 | GSK |
GSK plc
|
1,838,479 | $96,373,069 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $417,684,905 | 1,659,851 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $717,574,761 | 3,299,346 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $798,782,075 | 3,495,917 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $767,969,788 | 3,316,791 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $636,456,454 | 3,428,814 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $645,078,766 | 3,078,841 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $573,064,552 | 3,224,899 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $660,904,933 | 3,346,693 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $497,004,756 | 2,897,649 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $484,805,012 | 2,662,301 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $399,013,656 | 2,574,780 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $372,127,544 | 2,496,495 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $356,575,609 | 2,646,594 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $443,017,841 | 2,779,807 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $466,304,322 | 2,885,368 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $403,113,558 | 3,003,603 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $445,555,918 | 2,909,088 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $176,116,790 | 1,086,403 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $197,037,735 | 1,455,227 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $110,413,035 | 1,023,575 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $167,312,414 | 1,485,373 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $145,393,245 | 1,343,497 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $115,142,425 | 1,074,591 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $88,430,163 | 1,009,592 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $81,761,947 | 832,776 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $108,566,711 | 1,424,947 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||